AI-Powered Atopic Dermatitis Assessment: Patients Can Contribute + Small punch biopsies and non-negative matrix factorization (NMF) to study AD transcriptome + An important role of IL-22 in Th2 driven acute AD in epidermal reconstructs models + Health-Related Quality of Life in AD and Psoriasis: Are There Distinct Psychological Traits? + Towards a scientific approach of traditional Chinese medicine formulas
Read More
Rajka ISAD 2025 – A Landmark Symposium in the Asia-Pacific Region History, Memory, and Retelling – From Rajka’s Legacy to the Future of Atopic Dermatitis Melbourne, Australia | October 24–26, 2025 The 15th Georg RAJKA International Symposium on Atopic Dermatitis brought the global AD community together in Melbourne for a memorable event marking the centenary […]
Read More
Best Oral #1081 Comparative transcriptomic profiling of Asian atopic dermatitis and psoriasis reveals candidate molecular targets for precision therapyChang Ook PARK, South Korea Best Posters #1115 Multi-omic spatial profiling of atopic eczema skin reveals common transcriptional and proteomic immune targets altered with inhibiting interleukin 4 and interleukin 13 signalingNicholas P. WEST, Australia #1070 Regulatory role […]
Read More
Suppl. Vol. 105 (2025). Immediate open access Please get your copy (authors retain copyright): 10.2340/actadv.v105.44874 About ActaDV Acta Dermato-Venereologica publishes high-quality manuscripts in the field of Dermatology and Venereology, dealing with new observations on basic dermatological and venereological research, as well as clinical investigations. Each volume features a number of Original articles in special areas, […]
Read More
The 2025 issue showcases a diverse array of initiatives from our community, highlighting innovative approaches and projects in the field of dermatology. By sharing these key projects and learnings, we aim to educate and empower dermatologists and their societies globally.
Read More
Dear World Skin Health Coalition Partners, A first formal step on the road to implementation of the WHA Resolution on Skin Diseases following its adoption by Member States in May 2025. The World Health Organization (WHO) has launched a survey for Member States and relevant stakeholders to gather preliminary information on implementation of the Resolution […]
Read More
Better Worldwide Emollient Access for Atopic Dermatitis: Building Bridges between Patients, Academy and Industry The recent inclusion of urea 5% and glycerol 15–20% moisturizers on the WHO Essential Medicines List (EML/EMLc) marks a watershed moment for atopic dermatitis care — and a turning point for millions of underserved patients in low- and middle-income countries (LMICs). […]
Read MoreAI-Powered Atopic Dermatitis Assessment: Patients Can Contribute + Small punch biopsies and non-negative matrix factorization (NMF) to study AD transcriptome + An important role of IL-22 in Th2 driven acute AD in epidermal reconstructs models + Health-Related Quality of Life in AD and Psoriasis: Are There Distinct Psychological Traits? + Towards a scientific approach of traditional Chinese medicine formulas
Read More
Dear invited Participants of the next RAJKA-ISAD Melbourne 2025, We’ve received reports of a scam targeting our conference attendees. The scammer is sending emails that appear to be from a conference’s “reservation team” and are designed to look like legitimate reminders for hotel bookings. If your accommodation is covered: How to spot the scam: If […]
Read More
The International Society of Atopic Dermatitis (ISAD) and the World Health Organization (WHO) have successfully included urea- and glycerol-based moisturizing creams on the Essential Medicines Lists (EML and EMLc) for treating atopic dermatitis! This is a huge step forward for patient care worldwide, especially in low and middle-income countries (LMICs). By making these creams more […]
Read More